ENDOMETRIAL CLEAR CELL ADENOCARCINOMA
Clinical trials for ENDOMETRIAL CLEAR CELL ADENOCARCINOMA explained in plain language.
Never miss a new study
Get alerted when new ENDOMETRIAL CLEAR CELL ADENOCARCINOMA trials appear
Sign up with your email to follow new studies for ENDOMETRIAL CLEAR CELL ADENOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for advanced endometrial cancer: Three-Drug cocktails tested
Disease control OngoingThis study tested three different combinations of chemotherapy and targeted drugs in 349 people with advanced or recurrent endometrial cancer. The goal was to see which combination worked best to stop the cancer from growing or spreading. Participants received one of three treatm…
Matched conditions: ENDOMETRIAL CLEAR CELL ADENOCARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 17, 2026 07:04 UTC
-
New drug duo targets Hard-to-Treat brain tumors
Disease control OngoingThis early-phase trial tests a new drug (MLN0128) combined with bevacizumab in people with recurrent glioblastoma (a brain cancer) or other advanced solid tumors that have stopped responding to standard treatments. The main goals are to find the safest dose and understand side ef…
Matched conditions: ENDOMETRIAL CLEAR CELL ADENOCARCINOMA
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 11, 2026 20:50 UTC
-
Immunotherapy plus chemo shows promise for tough endometrial cancers
Disease control OngoingThis study tests whether adding the immunotherapy drug pembrolizumab to standard chemotherapy (paclitaxel and carboplatin) helps people with advanced or recurrent endometrial cancer live longer without the cancer growing. About 813 participants with stage III, IV, or recurrent di…
Matched conditions: ENDOMETRIAL CLEAR CELL ADENOCARCINOMA
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 05, 2026 11:54 UTC
-
New imaging methods could spare women unnecessary surgery for endometrial cancer
Knowledge-focused OngoingThis study looks at whether special scans (PET/CT) and a dye that highlights lymph nodes can find cancer that has spread from the womb in women with high-risk endometrial cancer. About 100 women will get both tests before surgery to see how well they work compared to standard sur…
Matched conditions: ENDOMETRIAL CLEAR CELL ADENOCARCINOMA
Phase: NA • Sponsor: M.D. Anderson Cancer Center • Aim: Knowledge-focused
Last updated May 15, 2026 11:55 UTC